MMWR News Synopsis for October 4, 2019
National Trends in Hepatitis C Infection by Opioid Use Disorder Status Among Pregnant Women at Delivery Hospitalization — United States, 2000–2015
The rate of hepatitis C infection among women at delivery – both with and without opioid use disorder – increased significantly between 2000 and 2015. CDC examined the relationship between the opioid crisis and national trends in hepatitis C virus (HCV) infections among women during hospital deliveries. Overall, the U.S. rate of HCV infection at delivery increased from 0.8 infections per 1,000 live births in 2000 to 4.1 in 2015. During this time period, among those women with opioid use disorder, the rates of HCV infection increased from 87 to 217 per 1,000 deliveries. Among those without opioid use disorder, the rate of HCV infection increased from 0.7 to 2.6 per 1,000 deliveries. Treatment of opioid use disorder should include screening and referral for related conditions such as HCV infection.
Evaluation of Infection Prevention and Control Readiness at Frontline Health Care Facilities in High-Risk Districts Bordering Ebola Virus Disease–Affected Areas in the Democratic Republic of the Congo — Uganda, 2018
During an Ebola outbreak, frontline healthcare facilities must have the capacity to rapidly identify suspected Ebola cases and refer suspected Ebola cases for treatment in order to protect patients, staff, and visitors. The 2014–2016 West Africa Ebola outbreak demonstrated the importance of strengthening infection prevention and control (IPC) capacity at frontline healthcare facilities to prevent healthcare–associated transmission. Shortly after the Ebola outbreak in the Democratic Republic of the Congo (DRC) was declared, Uganda initiated Ebola preparedness activities in districts bordering DRC. IPC assessments revealed gaps in screening, isolation, and notification practices at four frontline healthcare facilities. Rapid scale-up of IPC preparedness activities at facilities where the risk of encountering patients with Ebola is high must be undertaken to ensure that these facilities have the capacity to rapidly identify suspected Ebola cases and refer patients for treatment to protect patients, staff, and visitors.
Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2000–2018
Rubella is being eliminated country by country. For the first time, more than half of the world’s infants are protected against rubella. Since 2011, there has been an acceleration in the efforts to introduce rubella-containing vaccine using a strategy that can result in elimination. In 2018, more than half (69%) of the world’s infants were vaccinated for rubella. This is the highest-ever infant vaccination rate for rubella. Because of vaccination activities, 81 (43%) countries have stopped endemic rubella transmission, ending birth defects due to congenital rubella syndrome (CRS) in those countries. CRS is a condition that occurs after a mother is infected with rubella during pregnancy and can cause birth defects. Rubella and CRS are preventable through vaccination.